Skip to main content

Advertisement

Log in

Therapeutic Sesamol Attenuates Monocrotaline-Induced Sinusoidal Obstruction Syndrome in Rats by Inhibiting Matrix Metalloproteinase-9

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

We investigated the therapeutic effect of sesamol against monocrotaline-induced sinusoidal obstruction syndrome (SOS) in rats. Male Sprague–Dawley rats were gavaged with a single dose of monocrotaline (90 mg/kg) to induce SOS. Sesamol (5, 10, 20, and 40 mg/kg) was subcutaneously injected 24 h after monocrotaline treatment. Control rats were given saline only. Aspartate transaminase, alanine transaminase, mast cells, CD 68+ Kupffer cells, neutrophils, myeloperoxidase, matrix metalloproteinase-9 (MMP-9), tissue inhibitor of matrix metalloproteinase-1 (TIMP-1), laminin, and collagen were assessed 48 h after monocrotaline treatment. All tested parameters, except for TIMP-1, laminin, and collagen, were significantly higher in monocrotaline-treated rats than in control rats, and, except for TIMP-1, laminin, and collagen, significantly lower in sesamol-treated rats than in monocrotaline-treated rats. In addition, liver pathology revealed that sesamol offered significant protection against SOS. We conclude that a single dose of sesamol therapeutically attenuated SOS by decreasing the recruitment of inflammatory cells, downregulating MMP-9, and upregulating TIMP-1 expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Rubbia-Brandt, L., Audard, V., Sartoretti, P., Roth, A. D., Brezault, C., Le Charpentier, M., et al. (2004). Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Annals of Oncology, 15, 460–466.

    Article  CAS  PubMed  Google Scholar 

  2. Coppell, J. A., Brown, S. A., & Perry, D. J. (2003). Veno-occlusive disease: Cytokines, genetics, and haemostasis. Blood Reviews, 17, 63–70.

    Article  PubMed  Google Scholar 

  3. Deleve, L. D. (2007). Hepatic microvasculature in liver injury. Seminars in Liver Disease, 27, 390–400.

    Article  CAS  PubMed  Google Scholar 

  4. Baybutt, R. C., Rosales, C., Brady, H., & Molteni, A. (2002). Dietary fish oil protects against lung and liver inflammation and fibrosis in monocrotaline treated rats. Toxicology, 175, 1–13.

    Article  CAS  PubMed  Google Scholar 

  5. Stoyanova, I. I. (2004). Relevance of mast cells and hepatic lobule innervation to liver injury. Romanian Journal of Gastroenterology, 13, 203–209.

    PubMed  Google Scholar 

  6. Fondevila, C., Shen, X. D., Duarte, S., Busuttil, R. W., & Coito, A. J. (2009). Cytoprotective effects of a cyclic RGD peptide in steatotic liver cold ischemia and reperfusion injury. American Journal of Transplantation, 9, 2240–2250.

    Article  CAS  PubMed  Google Scholar 

  7. Jaeschke, H. (2006). Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. American Journal of Physiology-Gastrointestinal and Liver Physiology, 290, G1083–G1088.

    Article  CAS  PubMed  Google Scholar 

  8. Campian, M. E., Hardziyenka, M., de Bruin, K., van Eck-Smit, B. L., de Bakker, J. M., Verberne, H. J., et al. (2010). Early inflammatory response during the development of right ventricular heart failure in a rat model. European Journal of Heart Failure, 12, 653–658.

    Article  CAS  PubMed  Google Scholar 

  9. Deleve, L. D., Wang, X., Tsai, J., Kanel, G., Strasberg, S., & Tokes, Z. A. (2003). Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition. Gastroenterology, 125, 882–890.

    Article  CAS  PubMed  Google Scholar 

  10. Gieling, R. G., Wallace, K., & Han, Y. P. (2009). Interleukin-1 participates in the progression from liver injury to fibrosis. American Journal of Physiology-Gastrointestinal and Liver Physiology, 296, 1324–1331.

    Article  Google Scholar 

  11. Zhang, Y., Liu, P., Gao, X., Qian, W., & Xu, K. (2010). rAAV2-TGF-beta(3) decreases collagen synthesis and deposition in the liver of experimental hepatic fibrosis rat. Digestive Diseases and Sciences, 55, 2821–2830.

    Article  PubMed  Google Scholar 

  12. Coussens, L. M., & Werb, Z. (2001). Inflammatory cells and cancer: Think different! Journal of Experimental Medicine, 193, F23–F26.

    Article  CAS  PubMed  Google Scholar 

  13. Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000). MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell, 103, 481–490.

    Article  CAS  PubMed  Google Scholar 

  14. Narita, M., Hatano, E., Tamaki, N., Yamanaka, K., Yanagida, A., Nagata, H., et al. (2009). Dai-kenchu-to attenuates rat sinusoidal obstruction syndrome by inhibiting the accumulation of neutrophils in the liver. Journal of Gastroenterology and Hepatology, 24, 1051–1057.

    Article  PubMed  Google Scholar 

  15. Heissig, B., Rafii, S., Akiyama, H., Ohki, Y., Sato, Y., Rafael, T., et al. (2005). Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. Journal of Experimental Medicine, 202, 739–750.

    Article  CAS  PubMed  Google Scholar 

  16. Heissig, B., Nishida, C., Tashiro, Y., Sato, Y., Ishihara, M., Ohki, M., et al. (2010). Role of neutrophil-derived matrix metalloproteinase-9 in tissue regeneration. Histology and Histopathology, 25, 765–770.

    CAS  PubMed  Google Scholar 

  17. De Leve, L. D., Ito, Y., Bethea, N. W., McCuskey, M. K., Wang, X., & McCuskey, R. S. (2003). Embolization by sinusoidal lining cell obstructs the microcirculation in rat sinusoidal obstruction syndrome. American Journal of Physiology-Gastrointestinal and Liver Physiology, 284, G1045–G1052.

    Google Scholar 

  18. Fukuda, Y., Osawa, T., Namiki, M., & Ozaki, T. (1985). Studies on antioxidative substances in sesame seed. Agricultural and Biological Chemistry, 49, 301–306.

    Article  CAS  Google Scholar 

  19. Fukuda, Y., Osawa, T., & Namiki, M. (1994). Chemistry of lignan antioxidants in sesame seed and oil. In C. T. Ho, T. Osawa, M. T. Huang, R. T. Rosen (Eds.), Food phytochemicals for cancer prevention II: Teas, spices and herbs, Vol 547 (pp. 264–274). Washington, DC: ACS Symposium Series.

  20. Namiki, M. (1995). The chemistry and physiological function of sesame. Food Reviews International, 11, 281–329.

    Article  CAS  Google Scholar 

  21. White, J. P. (1992). Fatty acids in oil seeds. Fatty acids in foods and their health applications (pp. 237–262). New York, NY: Dekker M. Incorporated.

    Google Scholar 

  22. Fukuda, Y. (1990). Food chemical studies on the antioxidants in sesame seed. Nippon Shokuhin Kogyo Gakkaishi, 37, 484–492.

    Article  CAS  Google Scholar 

  23. Hsu, D. Z., Li, Y. H., Chu, P. Y., Chien, S. P., Chuang, Y. C., & Liu, M. Y. (2006). Attenuation of endotoxin-induced oxidative stress and multiple organ injury by 3, 4-methylenedioxyphenol in rats. Shock, 25, 300–305.

    Article  CAS  PubMed  Google Scholar 

  24. Hsu, D. Z., Chien, S. P., Chen, K. T., & Liu, M. Y. (2007). The effect of sesamol on systemic oxidative stress and hepatic dysfunction in acutely iron-intoxicated mice. Shock, 28, 596–601.

    CAS  PubMed  Google Scholar 

  25. Periasamy, S., Mo, F. E., Chen, S. Y., Chang, C. C., & Liu, M. Y. (2011). Sesamol attenuates isoproterenol-induced acute myocardial infarction via inhibition of matrix metalloproteinase-2 and -9 expression in rats. Cellular Physiology and Biochemistry, 27, 273–280.

    Article  CAS  PubMed  Google Scholar 

  26. Chu, P. Y., Chien, S. P., Hsu, D. Z., & Liu, M. Y. (2010). Protective effect of sesamol on the pulmonary inflammatory response and lung injury in endotoxemic rats. Food and Chemical Toxicology, 48, 1821–1826.

    Article  CAS  PubMed  Google Scholar 

  27. Chu, P. Y., Hsu, D. Z., Hsu, P. Y., & Liu, M. Y. (2010). Sesamol down-regulates the lipopolysaccharide-induced inflammatory response by inhibiting nuclear factor-kappa B activation. Innate Immunity, 16, 333–339.

    Article  CAS  PubMed  Google Scholar 

  28. Kuhad, A., Sachdeva, A. K., & Chopra, K. (2009). Attenuation of renoinflammatory cascade in experimental model of diabetic nephropathy by sesamol. Journal of Agriculture and Food Chemistry, 57, 6123–6128.

    Article  CAS  Google Scholar 

  29. Hsu, D. Z., Chen, K. T., Li, Y. H., Chuang, Y. C., & Liu, M. Y. (2006). Sesamol delays mortality and attenuates hepatic injury after cecal ligation and puncture in rats: Role of oxidative stress. Shock, 25, 528–532.

    Article  CAS  PubMed  Google Scholar 

  30. Hsu, D. Z., Chu, P. Y., Li, Y. H., & Liu, M. Y. (2008). Sesamol attenuates diclofenac-induced acute gastric mucosal injury via its cyclooxygenase-independent antioxidative effect in rats. Shock, 30, 456–462.

    Article  CAS  PubMed  Google Scholar 

  31. Geetha, T., Rohit, B., & Pal, K. I. (2009). Sesamol: An efficient antioxidant with potential therapeutic benefits. Medicinal Chemistry, 5, 367–371.

    CAS  PubMed  Google Scholar 

  32. Hsu, D. Z., Wan, C. H., Hsu, H. F., Lin, Y. M., & Liu, M. Y. (2008). The prophylactic protective effect of sesamol against ferric-nitrilotriacetate-induced acute renal injury in mice. Food and Chemical Toxicology, 46, 2736–2741.

    Article  CAS  PubMed  Google Scholar 

  33. Shenoy, R. R., Sudheendra, A. T., Nayak, P. G., Paul, P., Kutty, N. G., & Rao, C. M. (2011). Normal and delayed wound healing is improved by sesamol, an active constituent of Sesamum indicum (L.) in albino rats. Journal of Ethnopharmacology, 133, 608–612.

    Article  CAS  PubMed  Google Scholar 

  34. Hsu, D. Z., Chu, P. Y., & Liu, M. Y. (2009). The non-peptide chemical 3, 4-methylenedioxyphenol blocked lipopolysaccharide (LPS) from binding to LPS-binding protein and inhibited pro-inflammatory cytokines. Innate Immunity, 15, 380–385.

    Article  CAS  PubMed  Google Scholar 

  35. Kapadia, G. J., Azuine, M. A., Tokuda, H., Takasaki, M., Mukainaka, T., Konoshima, T., et al. (2002). Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis. Pharmacological Research, 45, 499–505.

    Article  CAS  PubMed  Google Scholar 

  36. Periasamy, S., Chen, S. Y., Hsu, D. Z., & Liu, M. Y. (2010). Comments on Vennila and Pugalendi. Vennila L, Pugalendi KV (2010) Protective effect of sesamol against myocardial infarction caused by isoproterenol in Wistar rats. Redox Rep 2010; 15: 36–42. Redox Report, 15, 288–289.

    Article  CAS  PubMed  Google Scholar 

  37. Shah, M. S., Jeevangi, N. K., Joshi, A., & Khattry, N. (2009). Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide. Journal of Cancer Research and Therapeutics, 5, 312–314.

    Article  PubMed  Google Scholar 

  38. Richardson, P. G., Soiffer, R. J., Antin, J. H., Uno, H., Jin, Z., Kurtzberg, J., et al. (2010). Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: A multicenter, randomized, dose-finding trial. Biology of Blood and Marrow Transplantation, 16, 1005–1017.

    Article  CAS  PubMed  Google Scholar 

  39. Chen, I. L., Yang, S. N., Hsiao, C. C., Wu, K. S., & Sheen, J. M. (2008). Treatment with high-dose methylprednisolone for hepatic veno-occlusive disease in a child with rhabdomyosarcoma. Pediatrics and Neonatology, 49, 141–144.

    Article  PubMed  Google Scholar 

  40. Al Beihany, A., Al Omar, H., Sahovic, E., Chaudhri, N., Al Mohareb, F., Al Sharif, F., et al. (2008). Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course of methylprednisolone. Bone Marrow Transplantation, 41, 287–291.

    Article  CAS  PubMed  Google Scholar 

  41. Chevallier, P., Prebet, T., Turlure, P., Hunault, M., Vigouroux, S., Harousseau, J. L., et al. (2010). Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplantation, 45, 165–170.

    Article  CAS  PubMed  Google Scholar 

  42. Sakaguchi, H., Watanabe, N., Muramatsu, H., Doisaki, S., Yoshida, N., Matsumoto, K., et al. (2010). Danaparoid as the prophylaxis for hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation in childhood hematological malignancy. Pediatric Blood & Cancer, 55, 1118–1125.

    Article  Google Scholar 

  43. Klinger, M., Eipeldauer, S., Hacker, S., Herberger, B., Tamandl, D., Dorfmeister, M., et al. (2009). Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases. European Journal of Surgical Oncology, 35, 515–520.

    Article  CAS  PubMed  Google Scholar 

  44. Rubbia-Brandt, L., Lauwers, G. Y., Wang, H., Majno, P. E., Tanabe, K., Zhu, A. X., et al. (2010). Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology, 56, 430–439.

    Article  PubMed  Google Scholar 

  45. Palmer, K. J., & Goa, K. L. (1993). Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders. Drugs, 45, 259–294.

    Article  CAS  PubMed  Google Scholar 

  46. Deng, F., Lu, L., Zhang, Q., Hu, B., Wang, S. J., & Huang, N. (2010). Henoch-Schönlein purpura in childhood: Treatment and prognosis. Analysis of 425 cases over a 5-year period. Clinical Rheumatology, 29, 369–374.

    Article  PubMed  Google Scholar 

  47. Risch, L., Huber, A. R., & Schmugge, M. (2006). Diagnosis and treatment of heparin-induced thrombocytopenia in neonates and children. Thrombosis Research, 118, 123–135.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This research was supported by grants NSC 99-2314-B-006-031-MY3 and NSC 99-2221-E-006-064-MY3 from the Taiwan National Science Council.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ming-Yie Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Periasamy, S., Hsu, DZ., Chen, SY. et al. Therapeutic Sesamol Attenuates Monocrotaline-Induced Sinusoidal Obstruction Syndrome in Rats by Inhibiting Matrix Metalloproteinase-9. Cell Biochem Biophys 61, 327–336 (2011). https://doi.org/10.1007/s12013-011-9215-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-011-9215-3

Keywords

Navigation